Understanding the comprehensive economic effects of age-related macular degeneration (AMD) could aid with decision-making in health care policy, economic planning, health technology assessments, medical research and public health initiatives, potentially leading to better health outcomes and more efficient use of resources. Despite the considerable deleterious effect AMD can have on visual function, it can be associated with adverse economic outcomes that can extend beyond the direct medical costs associated with treatment. People living with AMD often require additional support, including caregiving services, vision aids and rehabilitation, further escalating this burden. Read More